The Latest Medical News

A Summary of The Latest Medical News: **Mount Sinai's Groundbreaking AI Platform Revolutionizes Cancer Trial Access** Researchers at the Mount Sinai Tisch Cancer Center have launched PRISM, an innovative AI-powered platform designed to match more cancer patients across the health system with suitable clinical trials.[1][2][5] Developed by AI company Triomics, PRISM is powered by OncoLLM, a large language model specifically built for oncology care.[1][2][3] This makes Mount Sinai the first National Cancer Institute-designated Comprehensive Cancer Center in New York City to deploy an oncology-specific AI tool for systemwide clinical trial matching.[1][2][4] **Why This Matters for Cancer Patients** Clinical trials drive major advances in cancer treatment, yet only about 7% of patients participate due to barriers like limited awareness and access.[5] Historically, trial opportunities have been concentrated at major academic hospitals, leaving patients at community sites like Mount Sinai Queens, Brooklyn, South Nassau, Morningside, and West at a disadvantage.[1][2] PRISM changes that by analyzing electronic health records, diagnoses, and medical histories to identify eligible patients earlier and more equitably, reducing manual screening burdens on staff.[1][4][5] **Expert Insights on the Impact** “Clinical trials are essential to advancing cancer care, but too often patients and their treating physicians are not aware of studies that may be appropriate for them,” said Karyn Goodman, MD, MS, Professor and Vice Chair of Clinical Research in Radiation Oncology at Icahn School of Medicine at Mount Sinai, and Associate Director of Clinical Research at TCC.[1][2][5] By automating matches, the platform allows clinicians to focus on patient conversations rather than chart reviews, potentially boosting enrollment and outcomes for diverse communities.[1][5] **A Step Forward in Equitable Cancer Research** This systemwide rollout aligns with Mount Sinai's mission as an NCI-designated center, integrating research into everyday care and aiming to exceed national trial participation benchmarks.[1][2] The initiative stems from collaboration between Triomics, TCC, and Mount Sinai Research IT, with plans to evaluate results through peer-reviewed publications and scientific meetings.[1][2] As AI transforms healthcare, PRISM exemplifies how technology can bring cutting-edge trials closer to patients, no matter their location within the network.[4][6] Help with your insurance? https://tally.so/r/n012P9